Replimune (REPL) Receivables - Other (2018 - 2026)

Replimune has reported Receivables - Other for 9 years, with the latest figure at $1.6 million in Q1 2026.

• Quarterly Receivables - Other fell 57.05% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (down 57.05% YoY) and the FY2026 annual result came in at $1.6 million, down 56.54% from the prior year.
• Receivables - Other retreated to $1.6 million in Q1 2026 per REPL's latest filing, from $3.0 million in the prior quarter.
• Over five years, Receivables - Other peaked at $4.9 million in Q2 2024 and troughed at $1.6 million in Q1 2026.
• A 5-year average of $3.0 million and a median of $2.9 million in 2023 frame the typical range for Receivables - Other.
• The sharpest annual moves came in 2023 and 2025: Receivables - Other soared 115.18% in 2023, then plunged 62.64% in 2025.
• Over 5 years, Receivables - Other stood at $2.0 million in 2022, then soared by 115.18% to $4.3 million in 2023, then declined by 28.61% to $3.1 million in 2024, then retreated by 3.62% to $3.0 million in 2025, then tumbled by 45.85% to $1.6 million in 2026.
• According to Business Quant data, Receivables - Other over the past three periods registered $1.6 million, $3.0 million, and $1.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.